BIPROGY (8056) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
20 Oct, 2026Executive summary
FYMar2024 revenue rose 8.9% YoY to ¥370.1bn; operating profit increased 12.2% to ¥33.3bn as higher gross profit absorbed higher SG&A.
Strong DX demand and outsourcing activity supported higher revenue, orders and backlogs; adjusted operating profit reached ¥33.8bn.
Management policies for 2024–2026 prioritize core-business productivity, growth businesses, strategic investment and a more sustainable business portfolio.
Financial highlights
Revenue was ¥370.1bn, up ¥30.2bn YoY; gross profit was ¥97.2bn, up ¥7.8bn.
Operating profit was ¥33.3bn, up ¥3.6bn YoY; operating margin improved 0.3pt to 9.0%.
Profit attributable to owners of parent rose ¥5.0bn to ¥25.2bn, supported partly by lower income tax following application of the wage-increase tax measure.
Adjusted operating profit increased ¥4.4bn to ¥33.8bn; adjusted operating margin improved 0.5pt to 9.1%.
Orders rose 6.6% to ¥386.1bn; order backlog increased 5.8% to ¥289.8bn, with next-FY backlog up 4.3% to ¥140.9bn.
Outlook and guidance
FYMar2025 forecast: revenue ¥385.0bn (+4.0% YoY), operating profit ¥35.5bn (+6.6%), and adjusted operating profit ¥35.0bn (+3.5%).
FYMar2025 forecast operating margin is 9.2%; adjusted operating margin is 9.1%. Profit attributable to owners of parent is forecast at ¥24.5bn, down 3.0%.
FYMar2025 annual dividend forecast is ¥100 per share, targeting a payout ratio of 40% or more; FYMar2024 dividend was also ¥100 per share.
FYMar2027 targets: revenue ¥420bn, adjusted operating margin 11.0%, ROE 15.0% and dividend payout ratio of at least 40%.
FYMar2025 growth is expected to include ¥10.1bn more services revenue and ¥4.7bn more product sales; SG&A investment includes R&D, pay raises and a new personnel system.
Latest events from BIPROGY
- Q1 operating profit rose 22% as revenue, orders, and backlog grew.8056
Q1 2024 - H1 revenue rose 11.8% and operating profit 21.9%; FY guidance stayed unchanged.8056
Q2 2024 - 9M revenue and operating profit grew; full-year forecasts and dividends rose.8056
Q3 2024 - Deferred product sales cut Q1 profit, while orders surged and FY2027 guidance stayed unchanged.8056
Q1 2027 - Q1 revenue and operating profit grew, with full-year guidance unchanged.8056
Q1 2025 - Revenue and operating profit rose, but net profit declined; full-year guidance was unchanged.8056
Q2 2025 - Revenue and orders grew, lifting the FY revenue forecast despite lower net profit.8056
Q3 2025 - Revenue and operating profit grew; FY2027 revenue target rose to ¥440bn.8056
Q4 2025 - Q1 revenue and profit grew; full-year guidance remains unchanged.8056
Q1 2026